Blog – Page 24 – PHAGElogist

Special Issue on Bacteriophage Research

Special Issue on Bacteriophages, Submit your Research Now!

Special Issue "Bacteriophages: Infection, Genetics and Therapy" A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology". Deadline for manuscript submissions: 31 December 2022 https://www.mdpi.com/journal/life/special_issues/196IPXRO2G Special Issue Editors…

Phage-bacteria Co-evolution

Phage–host coevolution in natural populations Piel et al. 2022 Abstract: Coevolution between bacteriophages (phages) and their bacterial hosts occurs through changes in resistance and counter-resistance mechanisms. To assess phage–host evolution…

NEW Publication Alert!

Title: The Emergence of Carbapenem-Resistant Gram-Negative Bacteria in Mizoram, Northeast India Microbiol. Res. 2022, 13(3), 342-349; https://doi.org/10.3390/microbiolres13030027 Abstract (Background) Numerous reports on carbapenem resistance in different parts of India have been published, yet…

Phage Therapy Case Studies

A research team led by scientists from the University of Pittsburgh and the University of California San Diego reported 20 new case studies on the use of phage therapy, showing…

Phage Therapy and Mycobacterium Infection (TB)

Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease https://doi.org/10.1093/cid/ciac453 It’s the largest-ever set of published case studies for therapy using bacteria-killing viruses known as bacteriophages, providing…

Pitt researchers led the largest-ever series of phage therapy case studies

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. In a new paper published today in the journal Clinical Infectious Diseases, a team…

Antibiotic resistance crisis in post-pandemic world

On March 11, 2020, the World Health Organization (WHO) declared COVID-19, the disease caused by the SARS-CoV-2 virus, a pandemic. Two years later, the shadow of the Covid pandemic is…

Treatment of Severe Infections

Treatment of severe infections caused by pathogenic bacteria relies on “last resort” antibiotics, but rising resistance by “superbugs” to most clinically approved drugs leaves patients exposed to possible fatalities. Flinders…

Nanoparticle-phage therapy combination

Bacterial infections are becoming increasingly difficult to treat due to antibiotic resistance built up by bacteria as they evolve and adapt to medication. UCLA biomolecular engineers and their colleagues are…